Rothschild & Co Asset Management US’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Rothschild & Co Asset Management US’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-504,170	Closed	-$3.02M	–	530
2015 Q3	$3.02M	Sell	504,170 -61,659	-11%	-$428K	0.06%	289
2015 Q2	$3.87M	Sell	565,829 -599,362	-51%	-$3.81M	0.07%	281
2015 Q1	$7.07M	Buy	1,165,191 +103,069	+10%	+$686K	0.13%	233
2014 Q4	$7.36M	Sell	1,062,122 -21,451	-2%	-$158K	0.15%	207
2014 Q3	$8.82M	Sell	1,083,573 -29,217	-3%	-$229K	0.19%	171
2014 Q2	$9.05M	Buy	1,112,790 +136,230	+14%	+$1.03M	0.19%	183
2014 Q1	$7.66M	Buy	+976,560	New	+$8.26M	0.17%	214

Other funds holding SPPI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Rothschild & Co Asset Management US's SPPI Position: Q4 2015 in Review

Rothschild & Co Asset Management US sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2015, closing a stake of 504,170 shares — an estimated $3.02M sold.

Rothschild & Co Asset Management US first reported a position in SPPI in Q1 2014 and held it in 7 quarters. The position peaked at $9.05M in Q2 2014. 146 funds tracked by Wall St. Rank hold SPPI as of Q4 2015.

Rothschild & Co Asset Management US reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
Rothschild & Co Asset Management US sold 504,170 Spectrum Pharmaceuticals Inc shares in Q4 2015, an estimated $3.02M.
Rothschild & Co Asset Management US first reported a position in Spectrum Pharmaceuticals Inc in Q1 2014 and held it in 7 quarters.
Rothschild & Co Asset Management US's Spectrum Pharmaceuticals Inc position peaked at $9.05M in Q2 2014.
146 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2015.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2015, filed 16 Feb 2016.